These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 12924709)

  • 21. Nogo-A expression in oligodendroglial tumors.
    Jung TY; Jung S; Lee KH; Cao VT; Jin SG; Moon KS; Kim IY; Kang SS; Kim HS; Lee MC
    Neuropathology; 2011 Feb; 31(1):11-9. PubMed ID: 20487307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
    Hirose T; Ishizawa K; Shimada S
    Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors.
    Ishizawa K; Komori T; Shimada S; Hirose T
    Clin Neuropathol; 2008; 27(3):118-28. PubMed ID: 18552083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms.
    Otero JJ; Rowitch D; Vandenberg S
    J Neurooncol; 2011 Sep; 104(2):423-38. PubMed ID: 21193945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival.
    Takei H; Yogeswaren ST; Wong KK; Mehta V; Chintagumpala M; Dauser RC; Lau CC; Adesina AM
    J Neurooncol; 2008 Jan; 86(2):183-90. PubMed ID: 17690840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.
    Bannykh SI; Stolt CC; Kim J; Perry A; Wegner M
    J Neurooncol; 2006 Jan; 76(2):115-27. PubMed ID: 16205963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells.
    Blümcke I; Becker AJ; Normann S; Hans V; Riederer BM; Krajewski S; Wiestler OD; Reifenberger G
    J Neuropathol Exp Neurol; 2001 Oct; 60(10):984-93. PubMed ID: 11589429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors.
    Dickinson PJ; Sturges BK; Higgins RJ; Roberts BN; Leutenegger CM; Bollen AW; LeCouteur RA
    Vet Pathol; 2008 Mar; 45(2):131-9. PubMed ID: 18424825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
    Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
    Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection.
    Lu QR; Sun T; Zhu Z; Ma N; Garcia M; Stiles CD; Rowitch DH
    Cell; 2002 Apr; 109(1):75-86. PubMed ID: 11955448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunolocalization of the oligodendrocyte transcription factor 1 (Olig1) in brain tumors.
    Azzarelli B; Miravalle L; Vidal R
    J Neuropathol Exp Neurol; 2004 Feb; 63(2):170-9. PubMed ID: 14989603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression.
    Finzsch M; Stolt CC; Lommes P; Wegner M
    Development; 2008 Feb; 135(4):637-46. PubMed ID: 18184726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olig transcription factors are expressed in oligodendrocyte and neuronal cells in human fetal CNS.
    Jakovcevski I; Zecevic N
    J Neurosci; 2005 Nov; 25(44):10064-73. PubMed ID: 16267213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.
    Lindberg N; Jiang Y; Xie Y; Bolouri H; Kastemar M; Olofsson T; Holland EC; Uhrbom L
    J Neurosci; 2014 Oct; 34(44):14644-51. PubMed ID: 25355217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development.
    Liu Y; Wu Y; Lee JC; Xue H; Pevny LH; Kaprielian Z; Rao MS
    Glia; 2002 Oct; 40(1):25-43. PubMed ID: 12237841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated generation of oligodendrocyte progenitor cells from human induced pluripotent stem cells by forced expression of Sox10 and Olig2.
    Li P; Li M; Tang X; Wang S; Zhang YA; Chen Z
    Sci China Life Sci; 2016 Nov; 59(11):1131-1138. PubMed ID: 27785726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas.
    Decaestecker C; Lopes BS; Gordower L; Camby I; Cras P; Martin JJ; Kiss R; VandenBerg SR; Salmon I
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):391-402. PubMed ID: 9100670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical comparative analysis of GFAP, MAP - 2, NOGO - A, OLIG - 2 and WT - 1 expression in WHO 2016 classified neuroepithelial tumours and their prognostic value.
    Schwab DE; Lepski G; Borchers C; Trautmann K; Paulsen F; Schittenhelm J
    Pathol Res Pract; 2018 Jan; 214(1):15-24. PubMed ID: 29258767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.